In Brief
This article was originally published in The Rose Sheet
Executive Summary
Under an amendment to the FDA Safety and Innovation Act, which passed the U.S. Senate May 24, there will be no further delays in implementation of FDA’s final rule for sunscreen testing and labeling. More news in brief.